MRF aims phase one for 2014

A board to discuss future MS therapies in early stage (Phase I or II) trials.

MRF aims phase one for 2014

Postby rainer » Tue Nov 17, 2009 9:03 pm

A long way off for a phase one but better then "someday".

November 10, 2009 – Saratoga, CA– The Myelin Repair Foundation today released its first five-year report that includes a new set of ambitious goals for the second 5 years of its myelin repair research program.

The Promises Made, Promises Kept report summarizes the MRF’s scientific achievements as well as its advances in demonstrating that its Accelerated Research Collaboration™ model has effectively accelerated the rate of target discovery.

“We know two things today that we did not know five years ago,” says MRF Founder and President Scott Johnson. “First, we know that myelin can be repaired in animal models of MS. And second, we know that our ARC model has accelerated the pace of basic scientific discovery. There could be no better news for MS patients and others who have so generously supported our work for the past five years. Having said that,” continued Johnson, “our work will not be done until we can bring a myelin repair treatment to market.”
User avatar
Family Elder
Posts: 367
Joined: Thu Jan 17, 2008 4:00 pm


Return to Drug Pipeline


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service